Atlas Trials

Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease

Clinical trial NCT00113035 · COMPLETED

Trial details

NCT number
NCT00113035
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Study type
OBSERVATIONAL
Pompe Disease
Start date
2005-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.